| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |